Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Granexin gel for deep second-degree thermal burns
NCT04684121Phase 2Withdrawn
- Sponsor
- Xequel Bio
- Start
- Aug 2022
- Primary completion
- Aug 2024
01
Overview
A Phase 2 trial of zifogaptide in Thermal Burn, sponsored by Xequel Bio. Planned start Aug 2022; status: withdrawn.
02
Drugs
zifogaptide
03
Conditions
Thermal Burn
Beyond the preview
Go deeper on NCT04684121.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04684121.